Number of Shares
3.07 Mil
Current Holdings Value*
$641.56 Mil
% of Portfolio
15.16%
Total Estimate Gain
$220.02 Mil
% of Total Estimate Gain
35.14%

Select Biotechnology Portfolio's AbbVie Inc Holding Summary

As of 2025-02-28, Select Biotechnology Portfolio held 3.07 Mil shares of AbbVie Inc(ABBV), totaling $641.56 Mil. This investment constitutes 15.16% of their stock portfolio, and Select Biotechnology Portfolio now holds 0.17% of the outstanding AbbVie Inc(ABBV) stock.

The initial trade took place in 2021Q4. And since then Select Biotechnology Portfolio has made 8 purchases of ABBV, at an average price of $133.77, for a total of 4.68 Mil shares. In addition, there have been 6 sales at an average price of $160.56 for 1.61 Mil shares. Based on historical transaction data and ABBV's current price of $191.40, Select Biotechnology Portfolio's estimated gain on his ABBV holdings is $220.02 Mil, reflecting a 35.14% gain to date.

Select Biotechnology Portfolio ABBV ($191.40) Holding Chart

Select Biotechnology Portfolio ABBV ($191.40) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1